<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Women&#39;s Health Blog on Medium]]></title>
        <description><![CDATA[Stories by Women&#39;s Health Blog on Medium]]></description>
        <link>https://medium.com/@womenshealth-blog?source=rss-d18e0e1e374f------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*VvUC_UuCZudVW5n_M7BjeA.png</url>
            <title>Stories by Women&amp;#39;s Health Blog on Medium</title>
            <link>https://medium.com/@womenshealth-blog?source=rss-d18e0e1e374f------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 04:31:38 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@womenshealth-blog/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[More Than a Checklist: Women’s Mental Health and Postpartum Depression Screening in Canada]]></title>
            <link>https://womenshealth-blog.medium.com/more-than-a-checklist-womens-mental-health-and-postpartum-depression-screening-in-canada-b21906f7fb30?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/b21906f7fb30</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 16 Oct 2026 19:49:34 GMT</pubDate>
            <atom:updated>2026-10-16T19:55:27.116Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*vS_qVRUW80p9C5ceTgqn4Q.png" /></figure><p><strong>Author</strong>:<strong> </strong>Tashi Stampp, PhD Student in Population Health; School of Interdisciplinary Health Sciences, University of Ottawa | <strong>Editors</strong>: Emily Anne Opala and Romina Garcia de leon (blog coordinator) <strong>Reviewer</strong>: Dr. Anne TM Konkle</p><p><strong>Published</strong>: November 27th, 2026</p><p><strong>Note to the readers: </strong>This includes content relating to <a href="https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/postpartum-depression#:~:text=of%20psychosis.-,Signs%20%26%20Symptoms,-Every%20woman%20is">anxious or depressive thoughts after delivery</a>.<strong> </strong>The following quotes are experts from research papers that have either interviewed or collected data from real parents in Canada. Identity remains anonymous.</p><p><strong>The Hidden Mental Load of New Motherhood</strong></p><p>When a person’s identity transitions to that of a parent or caregiver, an assortment of new responsibilities is demanded of them. Some of this might stem from social circles sharing tips or expectations of parenthood, or from internal beliefs about what being a <em>“good parent” </em>might mean to them. Often what is overlooked, is the internal shift that occurs in this transitional period. The emotional and mental changes that emerge after delivery. Something hidden beneath the celebration of a child entering the world.</p><p><a href="https://doi.org/10.1176/appi.books.9780890425596">Postpartum depression </a>(PPD) is a growing <a href="https://www.who.int/teams/mental-health-and-substance-use/promotion-prevention/maternal-mental-health">public health concern</a> for Canadian women. Around <a href="https://www150.statcan.gc.ca/n1/daily-quotidien/190624/dq190624b-eng.htm">23% of new mothers</a> report symptoms of depression <a href="https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/postpartum-depression#:~:text=of%20psychosis.-,Signs%20%26%20Symptoms,-Every%20woman%20is">(e.g., sadness or low mood)</a> from pregnancy and up to one year <a href="https://www.who.int/teams/mental-health-and-substance-use/promotion%09prevention/maternal-mental-health">after delivery</a>. The Canadian health care system continues to fall short in addressing postpartum mental health needs. Failing to recognize or treat PPD can affect both parents and their families. Only a small number of women <a href="https://www-frontiersin-org.proxy.bib.uottawa.ca/journals/global-womens-health/articles/10.3389/fgwh.2023.1027409/full">who require care receive it</a>, and even fewer receive evidence-based treatment.</p><p><strong>Why Postpartum Depression Screening Looks Different in Canada</strong></p><p>In Canada, screening for PPD is not routinely done and is often left up to individual healthcare providers. This approach was informed by the <a href="https://www.cmaj.ca/content/194/28/E981">Canadian Task Force on Preventative Health Care</a> in 2022, who recommended against routine screening for PPD in primary care settings. Choosing not to implement universal screening is not just a lack of action; it is a policy decision that shapes whether PPD is identified and treated.</p><p>In contrast, the <a href="https://pubmed-ncbi-nlm-nih-gov.proxy.bib.uottawa.ca/26813211/">United States Preventative Services Task Force</a> emphasized the importance of implementing screening recommendations that maintain diagnostic accuracy, sound treatment, and efficient follow-up. The United States implemented routine screening for PPD in 2016.</p><p><strong>When <em>“Usual Care”</em> Isn’t Enough</strong></p><p>Across Canada, approaches to <a href="https://doi.org/10.1186/s13643-022-02022-2">PPD screening remain inconsistent</a>. Rather than routinely screening all new mothers, healthcare providers are encouraged to use their own judgment when identifying mental health concerns during prenatal and postpartum care, referred to as usual care.</p><p>But what does <em>“usual care”</em> actually look like for parents from racialized or marginalized backgrounds, who are often <a href="https://doi.org/10.1097/NMC.0000000000000889">underrepresented in research</a> and may already face systemic barriers within healthcare settings? And how much evidence is considered <em>“enough”</em> before action is taken.</p><p><strong>What Often Goes Unseen After Birth</strong></p><p>Research suggests that after childbirth, healthcare providers often focus primarily on the baby’s wellbeing while the emotional needs of the parents receive less consideration. This lack of visibility can reinforce a system where parents are left with feelings of isolation, guilt or shame as their feelings remain hidden beneath the surface.</p><p>A Canadian mother expressed their experience with PPD <a href="https://open.library.ubc.ca/collections/ubctheses/24/items/1.0386766"><strong><em>“[…] most of us are sobbing in our homes, you know, thinking that this sucks. And we have nobody to tell, and there’s guilt and shame and all this stuff that comes with it. And it’s actually really common [laughter], um, but […] it’s supposed to be positive, right?”</em></strong></a></p><p>Canadian mothers reported <a href="https://doi.org/10.1016/j.jogc.2018.03.010"><strong><em>“needing medical attention for self”</em></strong></a>. In practice, support for postpartum mental health relies heavily on provider judgment, available time, available financial resources, and <a href="https://www.besstlab.com/concept-explainer">mental health literacy</a>, all of which could vary across settings.</p><p><strong>When Policy Meets Real Life</strong></p><p>Public health decisions often involve difficult choices about <a href="https://journals.sagepub.com/doi/10.1177/1757975920913547">balancing potential risks and benefits</a> for communities. Deciding whether an intervention is worth implementing means asking questions like: Who may be left out? Or, who is benefiting? Canada’s current approach to PPD screening reflects more than a clinical recommendation, it reflects a broader system that determines which forms of evidence are strong enough to justify action.</p><p>In evidence-based medicine, Randomized Controlled Trials (RCTs) are often treated as the gold standard for evaluating interventions, because they are designed to isolate cause-and-effect relationships. However, RCTs require researchers to control many factors, which can result in study populations that don’t fully reflect the diversity of real-world experiences.</p><p>This tension is evident in Canada’s approach to PPD screening. The Task Force based its recommendation on a systematic review that found low certainty of evidence that routine screening improves maternal health outcomes. Because the available RCT evidence was limited, the Task Force determined that there was not enough evidence to support universal screening, and called for more high quality trials.</p><p><strong>The Value of Research That Captures Lived Experience</strong></p><p>For parents living with PPD, the consequences of these decisions are often found in everyday life, not clinical trials. An Afro-Canadian woman described being perceived as <em>“strong”</em> by health professionals as a barrier to receiving mental health services after delivery, stating,<strong><em> </em></strong><a href="https://rdcu.be/fhW3c"><strong><em>“[t]hey think maybe we are immune to depression”</em></strong></a>.</p><p>This sentiment reveals something that does not fit within the hierarchy of evidence that is used in policy-making. Yet, it does provide clear insight to the challenges that Canadian Black mothers may face navigating the mental health system after delivery.</p><p><strong>Questions to Consider</strong></p><p>If PPD is considered a growing public health concern for Canadian women and is associated with long-term consequences, what happens when healthcare systems rely on an approach that does not consistently identify those at risk? More importantly, how should decisions about implementing, or not implementing routine PPD screening be made? Should these decisions be based primarily on the <em>“gold standard” </em>of evidence, or should they consider the realities of clinical practice and the diverse experiences of Canadian parents? These questions require us to assess whose evidence is prioritized in policy-making and whose experiences may be overlooked in the process.</p><p>Canadian parents are experiencing the consequences in the meantime.</p><p><strong>Mental Health Resources: </strong>Postpartum depression looks different for everyone, if you or someone you know is experiencing <a href="https://www.camh.ca/en/health-info/mental-illness-and-addiction-index/postpartum-depression#:~:text=of%20psychosis.-,Signs%20%26%20Symptoms,-Every%20woman%20is">emotional discomfort, persistent sadness, anxiety</a>, difficulties bonding with your baby, or other mental health concerns, resources are available. While conversations around screening continue, recognition and support remain important for parents and families navigating this transitional period.</p><p><a href="https://bouncebackontario.ca/"><strong>Bounce Back</strong></a> — 1–866–345–0224</p><p><a href="https://halton.cioc.ca/record/LON6230"><strong>Connex Ontario Helpline</strong></a> — 1–866–531–2600</p><p><a href="https://www.camh.ca/en/patients-and-families/information-for-families"><strong>Help For Families From CAMH</strong></a></p><p><strong>For emergencies, call 911 or visit your nearest hospital’s emergency department.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b21906f7fb30" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[On Postpartum Psychosis: What do we know?]]></title>
            <link>https://womenshealth-blog.medium.com/on-postpartum-psychosis-what-do-we-know-3524e53220dc?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/3524e53220dc</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 02 Oct 2026 16:01:02 GMT</pubDate>
            <atom:updated>2026-10-02T16:01:02.104Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*vHlDJMhvpTh3i3mzygHVoA.png" /></figure><p>Author: Simone Vigod, MD, MSc, FRCPC<br>Editors: Romina Garcia de leon and Tashi Stampp (blog coordinators) <br>Published: October 2nd, 2026</p><p><strong>Question 1: What is postpartum psychosis, and how does it differ from postpartum depression or postpartum anxiety?</strong></p><p>Postpartum psychosis is a term for a severe episode of mental illness that occurs exclusively postpartum — usually starting in the early days to weeks after delivery. It is characterised by symptoms of mania (or a “mixed state” of mania and depression) and/or psychosis. Mania is the “opposite” of depression, characterised by a very high or irritable mood, decreased need for sleep, racing thoughts, uncharacteristically high energy and/or impulsivity and often grandiosity — an inflated sense of power or special abilities. Psychosis is a mental state where an individual has lost touch with what is real, and it can occur alongside depression or mania, or on its own.</p><p>Psychosis can present as hallucinations, hearing or seeing things that are not really there, and delusions, which are fixed false beliefs not based on reality or evidence. Psychosis is different from anxiety where a person worries that something bad might happen and knows that their worry is likely excessive, but has trouble controlling it. It is also different from obsessive thoughts such as recurring intrusive images, thoughts or ideas (even ones where people see themselves harming or think about harming their baby), but are frightened by the thoughts and do not intend to act on them. In psychosis, thoughts can also be jumbled or mixed up, called disorganized thinking. It would be rare to see “disorganized thinking” with postpartum anxiety or depression alone.</p><p>Postpartum psychosis is likely quite rare, perhaps about 1–2 in every 1000 deliveries. This is far less common than postpartum depression or anxiety which together affect about 200 in every 1000 postpartum women. Postpartum psychosis can be hard to diagnose. This is partly because symptoms can fluctuate widely even over the course of a day, and also because it occurs in the context of so many other environmental changes to which shifts in maternal mood and thought patterns are sometimes attributed (e.g., sleep deprivation, other new demands). Most patients and many clinicians are unfamiliar with it as it is so rare, which may make it harder to recognize than more common postpartum mental health issues such as depression or anxiety. Making that differentiation is essential, however, since manic, mixed or psychotic symptoms may lead patients to harm themselves, their infants or other children in the home if not treated.</p><p>Check out the video series that we did for the CANMAT Clinical Practice Guideline for the Management of Perinatal Mood, Anxiety and Related Disorders to learn more about postpartum depression, anxiety and psychosis, and better understand the differences between them.<br> <br><strong>Question 2: Are there any leads on what are the underlying mechanisms of postpartum psychosis?</strong></p><p>The unique timing of postpartum psychosis with a very rapid onset in the early postpartum period when there have been so many recent neuroendocrine and hormonal changes strongly suggests a primarily biological etiology. There are elevated risks in family members of those who have experienced it, suggesting a genetic component, and individuals with bipolar disorder appear to be at very high risk. In fact genetic studies have shown that the genetics of postpartum psychosis are closer to those of bipolar disorder than they are to primary psychotic disorders such as schizophrenia.</p><p><strong>Question 3: Who is most likely to get postpartum psychosis? Are there ways to use these risk factors to form preventive interventions?</strong></p><p>In individuals with a previous episode of postpartum psychosis, there is a very high risk for recurrence (~29%). The risk for those with bipolar disorder (without a prior episode of postpartum psychosis) is also higher than for those with no mental illness or a history of depression only. Sleep deprivation has been linked to its onset, similar to its role in relapse in other major mental illnesses. In these cases, the best preventive strategy is to maintain stability through medication and sleep protection. Medication strategies involve maintenance medications in those with known bipolar disorder, as well as prophylactic treatment upon delivery among those with a history of postpartum psychosis who were not taking maintenance medication during the pregnancy. Sleep protection strategies range from engaging support systems (partners, family, nursing) to avoid multiple nighttime wakenings to treatment of insomnia with psychological therapy and medication, if needed.</p><p>Postpartum psychosis can also occur in individuals with no personal or family history of any mental illness. Some researchers have tried to determine whether other factors like age, parity (i.e., how many pregnancies a person has had), education status, or other potential sociodemographic or psychological variables are linked to postpartum psychosis, but no clear risk factors have emerged in these cases. When there is no history or family history of postpartum psychosis or bipolar disorder, the best preventative strategy is to maintain awareness of symptoms for early identification and treatment.</p><p><strong>Question 4: How is postpartum psychosis treated, and how are remission rates?</strong></p><p>Postpartum psychosis is considered a medical emergency, and requires treatment in an inpatient hospitalization setting for the safety of the patient and her child. It is important to rule out a medical (particularly a reversible) cause of the symptoms, as the presentation can be similar to what is seen with a severe infection, some autoimmune disorders (severe thyroid disease) and neurological conditions, such as anti-NMDA receptor encephalitis. Some countries have specialised inpatient units called “mother-baby units” where they can be treated safely without as much separation from their newborns as would be necessary if admitted to a general unit without support for infant care. These are not available in Canada at this time.</p><p>Once the appropriate investigations have been conducted, the goal is treatment that can rapidly get the symptoms under control. In the acute phase, at this point, the most agreed upon recommendation is to follow a step-wise approach of initial benzodiazepines, followed by antipsychotic medication if the benzodiazepine is not sufficient to calm initial agitation, and then the initiation of lithium, which can then be continued to prevent relapse. In one study, almost all inpatients with postpartum psychosis went into remission with this approach during their inpatient hospitalization, and lithium protected against relapse at 1 year of follow-up. The protection against relapse was much less when patients were left taking antipsychotics alone after the acute phase. Electroconvulsive therapy (ECT) can be considered in the acute phase when this approach is not sufficient, and might even be a first course of action if the symptoms are very severe, such as if the patient is not eating or drinking, is actively suicidal, has psychotic depression or is otherwise demonstrating evidence of altered responsiveness (e.g., catatonia).</p><p>As a person recovers, careful monitoring and follow-up, as well as support for the patient and their family is highly important. In our CANMAT guideline for the Management of Perinatal Mood, Anxiety and Related Disorders published in the Canadian Journal of Psychiatry in 2025, we recommend involving caregivers, partners, the broader support system and even peer support to promote recovery.</p><p><strong>Question 5: What do you think are the 3 most important points for patients, families and clinicians to know about postpartum psychosis?</strong></p><p>In summary, I would say that I would want people to know:</p><p>Postpartum psychosis is treatable and is not your fault. Most people recover quickly and completely, and a large number never have another episode of illness.</p><p>If you suspect that you or a loved one is suffering with postpartum psychosis, consider this an emergency — call 911 or 988, or go right away to your nearest emergency Department.</p><p>It can sometimes be tricky to diagnose, with fluctuating symptoms amidst a new postpartum context where there are bound to be many changes. Ask for help, advocate for medical investigations to rule out possible underlying causes and follow the best evidence guidelines for treatment.</p><p>More information can be found in our CANMAT Clinician Pocket Guide and Seeds of Hope Patient and Family Guide, available in English and in French, here.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3524e53220dc" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The HPV Vaccine Reduces Cervical Cancer Deaths to Nearly Zero in Women: The Science Explained]]></title>
            <link>https://womenshealth-blog.medium.com/can-the-hpv-vaccine-reduce-cervical-cancer-deaths-to-nearly-zero-in-women-the-science-explained-190d72dadbca?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/190d72dadbca</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 18 Sep 2026 16:01:01 GMT</pubDate>
            <atom:updated>2026-09-18T16:53:19.922Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Ec9LTa5DtC6BD46ASbLcNA.png" /></figure><p><strong>Author: </strong>Dr. Raywat Deonandan, PhD in Epidemiology and Biostatistics, University of Ottawa | <strong>Editors</strong>: Tashi Stampp and Romina Garcia de leon (blog coordinators)</p><p><strong>Published: </strong>September 18th, 2026</p><p><strong>News outlets have recently reported that young women who received the HPV vaccine have a <em>“near 0%”</em> chance of dying from cervical cancer. Can you explain what the </strong><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00918-9/fulltext"><strong>researchers</strong></a><strong> mean by this?</strong></p><p>The “near 0%” wording is a shorthand for a striking population-level finding, rather than a prediction that any individual woman has literally zero risk. In the<a href="https://www.sciencedirect.com/science/article/pii/S0140673626009189"> 2026 study published in <em>The Lancet</em></a>, researchers examined cervical-cancer mortality in England following the introduction of routine HPV vaccination. Among women aged 20–24 during 2020–2024 (a group in which roughly 88–90% had been vaccinated at ages 12–13), there were zero deaths from cervical cancer, whereas around 23 deaths would have been expected based on historical rates.</p><p>The researchers therefore estimated a 100% reduction in mortality in this group. (Statistically, the actual number is probably somewhere between 84% and 100%, based on what we call a “95% confidence interval”). They also estimated that England’s vaccination programme had prevented approximately 200 cervical-cancer deaths through 2024.</p><p>“Near zero” is a reasonable way of communicating that cervical-cancer mortality has become extraordinarily rare in these highly vaccinated young cohorts. But this should not be interpreted as an individual’s lifetime risk being mathematically zero.</p><p><strong>The study also reports a 100% reduction in cervical cancer deaths in certain age groups. Is it safe to say the vaccine provides women a literal 100% guarantee of protection? Why or why not?</strong></p><p>No. In epidemiology, an observed 100% reduction does not mean a vaccine provides a lifetime 100% guarantee to every vaccinated individual. Rather, it means that no deaths occurred in the particular population during the period studied when some deaths would otherwise have been expected.</p><p>The uncertainty around the estimate is important. As noted above,<a href="https://pubmed.ncbi.nlm.nih.gov/42309117/"> for women aged 20–24 in 2020–2024</a>, the estimated mortality reduction was 100%, but its 95% confidence interval was 84–100%. This means that even in that observed group, there is a chance that the actual mortality reduction was 84%, not 100%. For readers unfamiliar with the arcane art of statistics, this can be understandably confusing.</p><p>Moreover, this was an observational population study rather than a randomized trial, the women are still young, and cervical cancer can occur later in life. HPV vaccines also protect against the HPV types responsible for the great majority, but not literally every possible cause of cervical cancer. So these numbers most certainly do not represent the actual lifetime risk of a randomly selected woman.</p><p>Indeed, the authors appropriately described their results as evidence that high vaccination coverage was “associated with” a substantial reduction in deaths, rather than being the cause of that reduction.</p><p>The result is nevertheless remarkable: zero cervical-cancer deaths occurred in an entire national population of women aged 20–24 over five years, compared with 23.1 expected deaths. The correct message is therefore not “the vaccine guarantees you will never die of cervical cancer,” but rather that early HPV vaccination appears capable of reducing the risk to extraordinarily low levels. And that’s a powerful, meaningful message.</p><p><strong>Parents often wonder why the HPV vaccine is recommended in middle school, for girls as young as 11 to 13 years old. Is it safe to vaccinate at this age, and why is receiving it before exposure to HPV so important?</strong></p><p>Yes. HPV vaccination has<a href="https://www.cdc.gov/vaccine-safety/vaccines/hpv.html"> an extensive safety record</a> in adolescents, and vaccination at this age is deliberate: the goal is to establish immunity before a child is ever exposed to HPV, not because anyone is making assumptions about when an individual child will become sexually active.</p><p>HPV is extremely common and is transmitted through intimate skin-to-skin contact. Once infection with a particular HPV type has occurred, vaccination cannot eliminate that existing infection. The vaccine is therefore much more useful when given beforehand.</p><p><a href="https://www.cdc.gov/hpv/vaccines/index.html">The CDC routinely recommends</a> vaccination at<a href="https://www.cdc.gov/hpv/hcp/vaccination-considerations"> ages 11–12</a> and permits it beginning at age 9, and notes that more than 15 years of monitoring support its safety, effectiveness, and durability. Common adverse effects are generally mild, such as injection-site pain, headache, or fever. Serious allergic reactions are rare.</p><p>Importantly, the new English mortality data provide unusually powerful real-world support for the timing of vaccination: the most dramatic reduction in cervical-cancer deaths occurred in the cohorts vaccinated at 12–13 years, when most recipients had not yet been exposed to HPV.</p><p>Vaccinating early is therefore best understood as preventive medicine in its purest form: establish protection years before the infection that can eventually cause cancer is likely to occur.</p><p><strong>Can you explain what herd immunity is, and why maintaining high HPV vaccination rates is still important, even when many people in a community are vaccinated?</strong></p><p>Herd immunity occurs when enough people in a population are immune to an infection that transmission becomes less likely. Importantly, this indirectly protects people who are not immune. The threshold for what determines “enough people” varies depending on many things, including how contagious a disease is, and the effectiveness of both vaccination and prior infection in conferring immunity.</p><p>With HPV, high vaccination coverage reduces the number of people carrying and transmitting vaccine-targeted HPV types, so even unvaccinated people can benefit. Studies have found declines in vaccine-targeted HPV infections among unvaccinated populations following vaccination programs that are consistent with herd immunity expectations.</p><p>But herd immunity is not an all-or-nothing threshold, and HPV presents particular challenges because it is extremely common, includes many different viral types, and spreads through intimate skin-to-skin contact. If vaccination coverage falls, more susceptible people enter the population and transmission can increase again, weakening that indirect protection.</p><p>Maintaining high coverage also matters for equity. People do not mix randomly, so national or provincial vaccination rates can conceal schools, communities, or social networks with much lower coverage. The goal, therefore, is not simply to reach some magic percentage and stop vaccinating. Rather, sustained high uptake provides strong direct protection to each new generation while also reducing circulation of cancer-causing HPV types throughout the population.</p><p><strong>If the HPV vaccine is so effective, why is cervical cancer screening still important for women who have been vaccinated?</strong></p><p>Cervical cancer screening remains important because HPV vaccination dramatically reduces risk but does not eliminate it. Current vaccines protect against the HPV types responsible for most cervical cancers. But they do not protect against every cancer-causing HPV type, and some women may have been exposed to HPV before vaccination or may not have received the full benefit of vaccination.</p><p>Screening (using HPV testing, Pap testing, or both, depending on local guidelines) provides a second layer of protection by detecting high-risk HPV infections or precancerous cervical changes before they develop into invasive cancer.</p><p>Vaccination and screening should therefore be viewed as complementary rather than competing strategies. Vaccination prevents most of the infections that cause cervical cancer, while screening identifies the smaller number of potentially dangerous infections that still occur. This combination is central to the<a href="https://www.who.int/initiatives/cervical-cancer-elimination-initiative"> World Health Organization’s strategy for eliminating cervical cancer as a public-health problem</a>, which pairs high HPV vaccination coverage with high screening and treatment coverage.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=190d72dadbca" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Science of Body Literacy: How Wearables Are Changing Women’s Health]]></title>
            <link>https://womenshealth-blog.medium.com/the-science-of-body-literacy-how-wearables-are-changing-womens-health-698c4558fec6?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/698c4558fec6</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 21 Aug 2026 16:01:01 GMT</pubDate>
            <atom:updated>2026-08-21T16:01:01.806Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Y6JwfDufqeOssnSmeUOHCw.png" /></figure><p><strong>Author:</strong> Shaghayegh Moghimikandelousi, PhD Candidate in Biomedical Engineering, McMaster University | <strong>Editors:</strong> Romina Garcia de leon and Tashi Stampp (blog coordinators)</p><p><strong>Published: </strong>August 21st, 2026</p><p><strong>What exactly is a wearable device and how can it support women’s health?</strong></p><p>To understand wearable devices in women’s health, it’s important to understand that there has been a fundamental limitation in women’s health monitoring that has persisted across different eras. Generally, women go to the clinic, measurements are taken and decisions are made based on a snapshot. However, the physiology of the female body is not static and there are changes at different timepoints. Hormones fluctuate at different stages such as puberty, pregnancy, and menopause. The problem is we are sampling a <a href="https://www.nature.com/articles/s41467-025-63501-3">dynamic system</a> as if it were <a href="https://www.nature.com/articles/s41467-025-63501-3">static</a>. One promising solution is biomonitoring which is the capturing of time-dependent physiological changes and data in this context.</p><p>To achieve this goal, wearable devices have been introduced.They integrate multiple sensing approaches to monitor both<a href="https://www.nature.com/articles/s41746-024-01183-9"> physical parameters</a>, such as basal body temperature, heart rate, vaginal temperature, and uterine contractions, and<a href="https://www.nature.com/articles/s41467-025-63501-3"> chemical biomarkers</a>, including hormones, glucose, and indicators of bacterial infection detected through sialidase- or DNA-based sensing methods. These sensors can be worn, attached or be close to the body to collect data over time such as smart textiles (e.g. bra, underwear and other clothing), smart watches, skin patches, devices that track walking and movement patterns, and small vaginal devices that continuously monitor parameters such as<a href="https://www.nature.com/articles/s41467-025-63501-3"> temperature</a>.</p><p>Common methods that are frequently used in wearable sensors are electrochemical biosensors which detect the analyte, by measuring small electrical changes produced when that substance undergoes a chemical reaction at the sensor surface. An example of this is<a href="https://www.nature.com/articles/s41551-022-00887-1"> continuous glucose</a> monitoring that is very common for monitoring diabetes (such as<a href="https://diabetes.jmir.org/2023/1/e43979"> gestational diabetes</a>). Another important shift is moving away from blood as the only source of sampling. Wearable sensors are using alternative fluid including<a href="https://www.nature.com/articles/s41565-023-01513-0"> sweat</a>, vaginal discharge and<a href="https://www.nature.com/articles/s41551-022-00887-1"> interstitial</a> fluid as anon-invasive sampling method.</p><p><strong>What does it really mean to build ‘body literacy’? How do these devices help a woman understand when something is actually wrong versus when her body is just doing what it’s supposed to do?</strong></p><p>One of the most important roles of wearable sensors is collecting the data over time which creates a pattern for individuals. Moreover, instead of comparing these health data to the population average, it allows one to build a personal baseline <a href="https://www.nature.com/articles/s41467-025-63501-3">over time</a>. So, in this context, building body literacy means helping women understand how their body functions or how their <a href="https://www.nature.com/articles/s41467-025-63501-3">pattern changes</a>. Especially for women’s health, recognizing menstrual-cycle patterns, changes in vaginal pH or discharge, fertility signals, pregnancy-related changes, hormone fluctuations, sleep, heart rate, temperature, and other measurable indicators are all very <a href="https://www.nature.com/articles/s41467-025-63501-3">crucial</a>. One of the common examples will be the correlation of <a href="https://academic.oup.com/humrep/article/2/8/631/619206">body temperature and ovulation</a>. Before ovulation <a href="https://academic.oup.com/endo/article/162/8/bqab087/6262699">estrogens</a> rise resulting in the lowering of body temperature. After ovulation, due to the increase of progesterone, the body temperature will rise around <a href="https://www.sciencedirect.com/science/article/pii/S1566070215300321?via%3Dihub">0.5–0.80C</a>. <a href="https://www.tandfonline.com/doi/full/10.1080/23328940.2020.1735927">Monitoring body temperature</a> can help women monitor their ovulation. Another example of emerging technologies are using the smart bras, <a href="https://www.nature.com/articles/srep38906">textile-based antennas</a>, and ultrasound patches which can help women track and understand normal breast tissue change and identify unusual patterns. These wearables can detect tissue change by monitoring the stiffness or <a href="https://link.springer.com/article/10.1007/s11235-023-00990-x">density of breast tissue</a> over time. Although these devices are not intended to be a replacement for clinical methods such as getting, they will increase the awareness of body change and encourage the earlier medical assessment.</p><p><strong>How effective are commercially-available wearables at monitoring women’s health variables?</strong></p><p>There are multiple wearable devices in the markets for breast tissue monitoring (e.g. iBreastExam®, Invenia ABUS 2.0, and SmartBra EZ Rose® ); temperature for fertility (e.g. Ava Bracelet, OvuFirst, OvulaRing, TempDrop™, and femSense); biometrics for pregnancy (e.g. Nuvo, and Bloomlife Connects); motion,gait pattern, and bone mineral density mainly for osteoporosis (e.g. Muvone, ActiGraph wGT3X-BT®, MoveMonitor, and<a href="https://www.nature.com/articles/s41467-025-63501-3"> OsteoBoost</a>). While commercially available wearables are effective for the continuous tracking of these variables, their effectiveness is dependent on the location and time of use. For example, daily activity will affect wrist-based temperature readings and make them more reliable at night when the body is at<a href="https://www.nature.com/articles/s41467-025-63501-3"> rest</a>. An alternative option is the vaginal lodger which provides a more stable temperature reading because it is less affected by the daily activity and environmental condition. As mentioned above, commercially available wearables are intended to support health monitoring rather than serve as alternatives to, or replacements for, professional medical<a href="https://www.nature.com/articles/s41467-025-63501-3"> assessment</a>.</p><p><strong>What are some of the biggest problems with the data we currently collect from wearables, and how can we make sure these devices are actually accurate and helpful for all women?</strong></p><p>One of the main challenges for wearable devices is the data collection which will be affected by the device placement, <a href="https://www.nature.com/articles/s41598-020-64185-z">movement</a> and even <a href="https://link.springer.com/article/10.1186/s12905-015-0212-3">individuals</a>. Many emerging wearable and mobile-health systems use AI or machine-learning algorithms to interpret data and provide feedback. However, vast amounts of these AI algorithms are developed using biased datasets that do not adequately represent <a href="https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S2589750020301862?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2589750020301862%3Fshowall%3Dtrue&amp;referrer=">women of different ages</a><a href="https://ieeexplore.ieee.org/document/10678664">, ethnicities, socioeconomic</a> backgrounds, or <a href="https://www.jmir.org/2024/1/e54242">gender identities</a>. To make these technologies more accurate and useful to the diverse population of women, all of the AI algorithms should be trained on a more diverse dataset and therefore create more clinically <a href="https://www.nature.com/articles/s41467-025-63501-3">relevant algorithms</a>. After that the error rates and limitations should be reported clearly and be designed with accessible interfaces and professional guidance for interpreting the <a href="https://www.nature.com/articles/s41467-025-63501-3">results</a><strong>.</strong></p><p><strong>How useful is this data for clinicians, and how can these technologies be integrated into professional care?</strong></p><p>Data collected from wearable devices are very useful for the clinicians by providing continuous information rather than just single measurement. It can help by showing trends and even treatment responses or any further changes <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10727511/">that seek medical attention</a>. They are more effective when they are integrated into a <a href="https://link.springer.com/article/10.1186/s12884-025-07244-5">mobile health (mHealth)</a> App or <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10727511/">telemedicine</a> that allows clinicians and professionals to review that data.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=698c4558fec6" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What You Missed | July 2026]]></title>
            <link>https://womenshealth-blog.medium.com/what-you-missed-july-2026-6ffe8df71e67?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/6ffe8df71e67</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 14 Aug 2026 16:01:02 GMT</pubDate>
            <atom:updated>2026-08-14T16:01:02.666Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*rSTdNPsiG9uHyuHX2vT81g.png" /></figure><p>Science moves fast, and discoveries often pass by before we’ve had a chance to unpack them. This series is your monthly catch up with a science‑savvy friend: it’s evidence-based, accessible, and a little curious. Each post highlights meaningful new women’s health or sex and gender research from around the globe and asks the question: what does this really tell us about how our minds, bodies, and societies work?</p><p><strong>Author: </strong>Tashi Stampp, PhD Student, University of Ottawa (Blog coordinator)</p><h3>Ovary Shifts to Immune Organ</h3><p><strong>Title: </strong><a href="https://academic.oup.com/molehr/article/32/2/gaag038/8705536?login=false">The post-reproductive ovary shifts from a reproductive to an immune-like organ</a></p><p><strong>Authors: </strong>Aubrey Converse , Shweta S Dipali , Ian P Schowe , Emmett B Kelly , Shivani S Jambunathan , Sarah R Ocañas , Michael B Stout , Michele T Pritchard and Francesca E Duncan</p><p><strong>Journal:</strong> Molecular Human Reproduction</p><p><strong>Where is this research coming from? </strong>United States</p><p>The menopausal transition is biologically marked by the gradual decline of ovarian follicles, the structures that contain and support eggs and produce reproductive hormones. They are essential parts of the ovarian system that are mainly known to support the reproductive lifespan. Since females are born with a fixed number of follicles, this supply naturally declines over their lifetime until menopause. While much research has focused on fertility, miscarriages, birth defects and hormone loss. Far less is known about the function of the ovaries after reproduction ends, in post-menopausal women.</p><p>Through pre-clinical research, researchers examined a sample of post-reproductive mice, who experience ovarian aging similar to humans. They found that rather than becoming inactive, the post-reproductive ovary appeared to take on an <a href="https://academic.oup.com/molehr/article/32/2/gaag038/8705536?login=false"><strong><em>“immune -like”</em></strong></a>, <strong>inflammatory role, </strong>and different immune cells were found in the ovaries , suggesting it may continue to influence the body by producing signals involved in the process of aging.</p><p><strong>What does this mean?</strong></p><p>The research findings challenge the idea that the ovary becomes inactive after menopause. The study suggests that post-menopausal ovaries continue to evolve (on a molecular level) with age and may contribute to an important role in the immunal health of people who menstruate, influencing inflammation. Although the study’s research was conducted in mice, it lays the groundwork for future women’s health research and opens new avenues to improve our understanding of healthy aging after menopause.</p><p><strong>Questions We’re Pondering</strong></p><ul><li>These findings are promising, but what do we still need to learn before they can be used to improve women’s health through clinical care?</li><li>If the ovaries continue to evolve, and perhaps become a source of immune signalling — how does this new role play into the whole body system? Is this compensating for another immune organ?</li><li>Can these findings have implications for how we approach menopause? Could the ovaries becoming an immune-like organ contribute to any symptomology in menopause?</li></ul><h3>Gendered Stigma in Healthcare</h3><p><strong>Title:</strong> <a href="https://doi-org.proxy.bib.uottawa.ca/10.1016/j.socscimed.2026.119564">When class silences disclosure: Working-Class women, sexual violence and classed gender stigma in healthcare</a></p><p><strong>Authors: </strong>Karen Lorimer, Pamela Sime and Lesley McMillan</p><p><strong>Journal: </strong>Social Science &amp; Medicine</p><p>Note to readers: The content below discusses research on sexual violence and sexual assault against women. If you or someone you know has been affected by sexual violence, please know that <a href="https://www.camh.ca/-/media/health-info-files/community-resource-sheets/trauma-resources-pdf.pdf"><strong>support is available</strong></a>. You are not alone.</p><p><strong>Where is this research coming from? </strong>Scotland</p><p>Despite countless years of activism and advocacy against sexual violence, progress is reported to be low. Suggesting that this issue is rooted in our systems, institutions, and structures (such as policy, leadership, funding for research), rather than being the responsibility of individuals alone. The authors point that sexual violence is often shaped by broader soceital structures that determine whose disclosures are acknowledged as real experiences, or whose access to supportive resources are limited. The term <strong>classed gender stigma</strong> describes how the credibility of working-class women may be judged by health care providers during medical appointments. It was used to explore how the intersection of class and gender influences women’s willingness to disclose experiences of sexual violence in health care settings.</p><p>To better understand this issue, the researchers conducted interviews with women between the ages of 25 and 58 who lived in Scotland and had experienced sexual violence within the previous two years. Each woman met with an interviewer over Zoom for approximately 45 to 70 minutes to discuss their experiences. Following the interviews, the researchers used thematic analysis (i.e., identifying recurring patterns and themes across the narratives). The findings showed that histories of dismissal, limited access to resources, and societal expectations around “respectability” shaped women’s expectations of whether they would be believed and whether health care settings were safe places to disclose their experiences of sexual violence.</p><p><strong>What does this mean?</strong></p><p>Disclosing sexual violence or traumatic experiences to a health care providers is not simple for every woman. These encounters are shaped by social class, which can influence the type of health care women receive. Not only that, but also whose disclosures are recognised as credible and, ultimately, who is viewed as deserving of care after experiencing sexual violence</p><p><strong>Questions We’re Pondering</strong></p><ul><li>How much do societal expectations of “respectability” shape women’s expectations in a similar context, but in a different country? Would similar feelings evolve, or would different social expectations take precedent?</li><li>Of the woman who feel comfortable enough to disclose their experience with sexual violence, are there any insights relating to how they felt willing to do so, as a form of advice for other women who may be struggling with this?</li><li>What are the potential health consequences of not disclosing experiences of sexual assault? Could these experiences become biologically embodied and show up in other areas of women’s health or healthcare settings?</li></ul><h3>Sex, Gender and Haematology</h3><p><strong>Title: </strong><a href="https://share.google/XDnyJUtOLypB1PcvX">Female reproductive health — what the classical haematologist needs to know</a></p><p><strong>Authors:</strong> Bethany Samuelson Bannow, Imo Akpan and Maureen K Baldwin</p><p><strong>Journal:</strong> The Lancet Haematology</p><p><strong>Where is this research coming from? </strong>International</p><p>Haematologists are medical specialists who diagnose, prevent and treat diseases of the blood, lymphatic system, and bone marrow (e.g., sickle cell disease, anemia, and leukemia). They work in multidisciplinary health care settings where women and girls have increasingly become a large proportion of patients over the past 10 to 15 years. Today, around <a href="https://share.google/XDnyJUtOLypB1PcvX">42% of referrals</a> to haematology treatment centres are directed to women.</p><p>The authors explain that this shift requires greater collaboration between haematology and obstetrics and gynaecology (OB-GYN), as reproductive health topics have traditionally received limited attention in standard haematology training. The researchers conducted a review exploring key reproductive life stages that haematologists and women’s health providers should consider when caring for patients. Four important transitions are highlighted:</p><ol><li><strong>Adolescence and menarche:</strong> Menstrual history plays an important role in diagnosis, as heavy menstrual bleeding during adolescence can be one of the earliest signs of an underlying bleeding disorder.</li><li><strong>Pregnancy: </strong>Pregnancy and the postpartum period involve major haematological changes, including changes in blood volume and clotting, that require careful monitoring.</li><li><strong>Labour and delivery:</strong> The duration and timing of labour may influence decisions on when to safely administer anticoagulant (e.g., blood thinner’s) or haemostatic (medicine that slows down bleeding) therapies for patients with blood disorders.</li><li><strong>Perimenopause and menopause: </strong>New or worsening heavy menstrual bleeding during the menopausal transition may signal an underlying haematological condition. The average age of menopause is around 51 years in the United States but tends to occur earlier in many low- and middle-income countries.</li></ol><p><strong>What does this mean?</strong></p><p>Women make up a large proportion of haematology patients, yet many reproductive health considerations are not routinely included in haematology training. Understanding how adolescence, pregnancy, childbirth, and menopause influence blood health can help health care providers recognize symptoms earlier, improve treatment decisions, and provide more comprehensive care throughout a woman’s life transitions.</p><p><strong>Questions We’re Pondering</strong></p><ul><li>Why aren’t healthcare providers being informed on the impact of hematology in women, and how can medical education systems continue to inform providers on this knowledge gap?</li><li>Many young women and people who menstruate may not be diagnosed with menstrual or bleeding disorders until they experience difficulties trying to get pregnant. How can delayed diagnosis affect them, and what can we do to make these conditions easier to recognize and diagnose earlier?</li><li>How could haematology and obstetrics and gynaecology experts work together to better identify health disparities affecting women? Is more collaborative training realistic, given the demands and workload of clinical practice?</li></ul><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6ffe8df71e67" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Menstrual Blood May Be One of Medicine’s Most Overlooked Research Tools]]></title>
            <link>https://womenshealth-blog.medium.com/menstrual-blood-may-be-one-of-medicines-most-overlooked-research-tools-78427e37b05b?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/78427e37b05b</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 07 Aug 2026 16:10:56 GMT</pubDate>
            <atom:updated>2026-08-07T16:10:56.824Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>Author:</strong> Hala Salah, BSc Student, University of Calgary | <strong>Editors</strong>: Romina Garcia de leon, Tashi Stampp (blog coordinators) <strong>Reviewer:</strong> Mateja Perovic</p><p><strong>Published:</strong> August 7th, 2026</p><p><strong>Rethinking an Everyday Biological Sample</strong></p><p>When most people think about medical testing, they picture needles, vials, and laboratory blood draws. Blood testing has become one of the most common tools in healthcare. It can help detect health problems early and <a href="https://doi.org/10.1016/j.amjms.2024.04.009">diagnose disease and infection</a>. Despite how routine blood testing has become, <a href="https://doi.org/10.1097/MS9.0000000000002261">it is not always easy or accessible for everyone</a>. Because of its <a href="https://doi.org/10.16966/2572-9578.130">invasive</a> nature, <a href="https://doi.org/10.1097/MS9.0000000000002261">many people experience pain</a> or anxiety around needles, increasing <a href="https://doi.org/10.1101/2024.03.22.24304704">reluctance to participate voluntarily</a> in research. Traditional blood testing also requires specialized equipment and providers, <a href="https://doi.org/10.1097/MS9.0000000000002261">increasing health costs significantly</a>.</p><p>Every month, <a href="https://doi.org/10.1101/2024.03.22.24304704">1.8 billion people</a> naturally produce another biological sample. Researchers are now starting to realize <a href="https://doi.org/10.1101/2024.03.22.24304704">that it may hold equally valuable medical information</a>.</p><p><strong>What Makes Menstrual Blood Different?</strong></p><p>Menstrual blood as a biospecimen has been long ignored in medicine and research settings. For decades, it has been <a href="https://doi.org/10.1097/MS9.0000000000002261">treated as waste</a> and an “inconvenience” rather than as a potential source of scientific insight. This growing field provides a unique look into <a href="https://doi.org/10.16966/2572-9578.130">reproductive health, immunity, and physiological processes</a> occurring throughout the body. It is part of a larger shift in women’s health research: recognizing that menstruation isn’t just a monthly inconvenience, but a complex biological process that may tell us more about our health than previously understood.</p><p>One reason menstrual blood has been misunderstood is because of its misleading name. Menstrual fluid is not just blood leaving a woman’s body every month. It is a biologically complex mixture of <a href="https://doi.org/10.1074/mcp.M112.018390">blood, cells from the uterine lining, proteins, immune cells, hormones, and other biological material released during the menstrual cycle</a>. Proteomic analyses have identified hundreds of proteins in menstrual blood, including <a href="https://doi.org/10.1101/2024.03.22.24304704">approximately 400 proteins</a> not typically found in systemic blood.</p><p>One example of a unique menstrual blood biomarker is <a href="https://doi.org/10.1074/mcp.M112.018390">urocortin 3</a>. This protein is involved in <a href="https://doi.org/10.1074/mcp.M112.018390">inflammation, blood vessel activity and programmed cell death.</a> Because inflammation plays a major role in many gynecological diseases, tracking proteins like urocortin 3 in menstrual blood may provide researchers with a more direct window into what is happening within the uterus than a traditional blood sample.</p><p>This wealth of proteins makes menstrual blood a valuable diagnostic tool. It can show signs of inflammation and <a href="https://doi.org/10.1074/mcp.M112.018390">possible health issues</a>. It also provides insights into menstrual cycle regularity and <a href="https://doi.org/10.1101/2024.03.22.24304704">overall health status</a>.</p><p><strong>A New Window into Women’s Health</strong></p><p>Researchers are especially interested in menstrual blood because many gynecological conditions are strongly linked to <a href="https://doi.org/10.1074/mcp.M112.018390">abnormalities in immune and inflammatory pathways</a>. Since menstrual fluid comes directly from the <a href="https://doi.org/10.1074/mcp.M112.018390">uterine environment</a>, it can contain many biomarkers that may provide clues about diseases that are often difficult to diagnose and monitor.</p><p>For instance, emerging research on menstrual blood is particularly meaningful for endometriosis — <a href="https://doi.org/10.1097/MS9.0000000000002261">a condition where the growth of the uterine tissue occurs outside the uterus leading to infertility and severe pain</a>. Despite affecting over <a href="https://doi.org/10.1097/MS9.0000000000002261">190 million people worldwide</a>, diagnosis often takes years because symptoms are normalized and <a href="https://doi.org/10.1097/MS9.0000000000002261">diagnosis usually requires invasive procedures</a>. Researchers are now exploring whether menstrual blood could help improve non-invasive diagnosis because the disease is strongly <a href="https://doi.org/10.1097/MS9.0000000000002261">associated with inflammation and immune dysfunction</a>. Because menstrual fluid contains endometrial tissue and inflammatory proteins, scientists have <a href="https://doi.org/10.1097/MS9.0000000000002261">identified biomarkers that appear elevated in people with endometriosis</a>.</p><p>Specifically, <a href="https://doi.org/10.1097/MS9.0000000000002261">CXCL5 and IL1RN are examples of inflammatory proteins that have been found at significantly higher levels</a> in menstrual blood from people with endometriosis than in healthy individuals.</p><p>Though still in the experimental stage, these results suggest that menstrual blood could lead to earlier, easier diagnosis of endometriosis. This could mean faster recognition, fewer delays, and less invasive care for those living with chronic pain.</p><p><strong>Innovations in Menstrual Blood Collection</strong></p><p>Several methods for collecting menstrual blood non-invasively for diagnosis and research purposes are being explored. This has included menstrual cups, tampons, sanitary pads, absorbent sponges, and newer wearable technologies. However, some collection methods can still feel uncomfortable or inconvenient for users.</p><p>To address these barriers, researchers are developing less invasive and more accessible collection technologies. One example, <a href="https://doi.org/10.1101/2024.03.22.24304704">MenstruAI</a>, is a wearable <a href="https://doi.org/10.1101/2024.03.22.24304704">diagnostic platform directly integrated into a sanitary pad</a> that can detect biomarkers in menstrual blood without requiring separate sample collection or laboratory processing. <a href="https://doi.org/10.1101/2024.03.22.24304704">Results can be linked to a smartphone</a>, helping identify signs of inflammation, infection, cancer, and endometriosis. Technology like <a href="https://doi.org/10.1101/2024.03.22.24304704">MenstruAI</a> could make menstrual health monitoring more convenient, affordable, and accessible while helping transform a biological sample often treated as waste into a valuable source of health information. These non-invasive technologies can also be used from home. This may be especially valuable in underserved or low-resource settings where access to healthcare professionals and laboratory infrastructure is limited.</p><p>Despite its potential, menstrual blood research is still in its early stages. However, researchers still need to better understand how reliable these tests are, how samples should be collected and stored, and how these tools can be used safely and affordably in real healthcare settings. Menstrual blood is unlikely to replace conventional blood testing entirely, and many of these technologies will require further validation before widespread clinical use.</p><p><strong>Redefining Menstrual Blood in Medicine</strong></p><p>However, the growing interest in menstrual fluid diagnostics reflects something much larger than a new testing method alone. Ultimately, menstrual blood research is not simply about finding alternative ways to collect biological samples, but rather represents a shift toward more inclusive, accessible, and patient-centered healthcare. By studying menstrual fluid more seriously, researchers may uncover new opportunities for earlier diagnosis, personalized medicine, and improved understanding of diseases that have historically been overlooked. What was once dismissed as waste may ultimately become one of medicine’s valuable and accessible sources of health information.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=78427e37b05b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Testosterone & Women’s Health: What the Evidence Shows]]></title>
            <link>https://womenshealth-blog.medium.com/testosterone-womens-health-what-the-evidence-shows-6e578860f9c9?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/6e578860f9c9</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 24 Jul 2026 17:06:22 GMT</pubDate>
            <atom:updated>2026-07-24T17:06:22.112Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*xDoVlLjutvePoXFq-C5l1A.png" /></figure><p><strong>Author: </strong>Dr. Susan Davis, MBBS, FRACP, PhD, FAHMS, NHMRC L3 Investigator Director, Women’s Health Research Program Monash University | <strong>Editors</strong>: Tashi Stampp and Romina Garcia de leon (blog coordinators)</p><p><strong>Published: </strong>July 24th, 2026</p><p><strong>What role does testosterone play throughout the reproductive years? And what is the trajectory of testosterone throughout the lifespan? Does it decrease during menopause?</strong></p><ol><li>Testosterone is important for the ovaries to produce an egg, for normal body hair, and for many tissues throughout the body including the brain.</li><li>Testosterone is also converted into estrogen throughout the body so it is an important source of estrogen production.</li><li>Testosterone blood levels decline with age until about 60 years after they gradually increase.</li><li>Testosterone blood levels do not appear to change with natural menopause in any study.</li></ol><p><strong>We hear mainly about estradiol-based hormone therapy for menopausal symptoms, do some women get testosterone therapy? Is it given alone or in conjunction with estradiol based hormone therapy? And what route of administration is recommended?</strong></p><p>Some women receive testosterone for low libido after menopause. Many women are given it for other reasons but all of these are unproven theoretical effects. Testosterone should only be given as a skin based treatment (e.g. as a skin cream or gel but the only formulation approved by regulators is a testosterone cream).</p><p>The gels women often are prescribed are for men and women have to best guess the dose. Also, the use of compounded testosterone therapies are not supported by any credible organisations.</p><p><strong>If you could share one thing about testosterone that you wish every woman knew, what would it be?</strong></p><p>Testosterone treatment is not a <em>“magic bullet”</em> or the <em>“missing hormone”</em>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6e578860f9c9" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Tracing Black Women’s Pain and the Impacts on Black Maternal Health Today]]></title>
            <link>https://womenshealth-blog.medium.com/tracing-black-womens-pain-and-the-impacts-on-black-maternal-health-today-1a5609bcd621?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/1a5609bcd621</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 10 Jul 2026 16:01:01 GMT</pubDate>
            <atom:updated>2026-07-10T16:01:01.629Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*NVXGeZ8Muy9JVQo9dWBr8w.png" /></figure><p><strong>Author</strong>: Stephanie Awotwi-Pratt BSc., BA, MA <strong>| Editors</strong>: Romina Garcia de leon, Janielle Richards (blog coordinators) <strong>Reviewer</strong>: Tashi Stampp</p><p><strong>Note to the readers:</strong> This blog discusses difficult subject matter such as sexual violence and enslavement.</p><p><strong>Colonialism and the Lasting History of Black Women’s Lives</strong></p><p>In the enslavement era, Black women were thought not to experience pain, such that white physicians like Dr. James Marion Sims who founded the field of obstetrics <a href="https://doi.org/10.2307/j.ctt22726wh">operated on Black enslaved women without pain medication or local anesthesia.</a> Additionally, many white physicians of the 18th and 19th centuries believed that Black women inherently lacked civility thus used enslaved women <a href="https://doi.org/10.1016/j.socscimed.2022.115365">as sites of medical experimentation</a>.</p><p>Also considered <a href="https://doi.org/10.2307/j.ctt1pwt69x">“medical superbodies” or medical guinea</a> pigs, the Black enslaved body was hypersexualized and viewed as a living cadaver for white physicians to dissect and extract knowledge used to treat white women of the time. The prevailing assumption by physicians at the time was that <a href="https://doi.org/10.2307/j.ctt1pwt69x">enslaved women did not feel “physical pain”</a> in comparison to the civilized white women of the colonial era.</p><p><a href="https://doi.org/10.2307/j.ctt1pwt69x">Scholars write about how pregnant enslaved women suffered harsh working conditions </a>and extreme physical labour tasks regardless of their physically vulnerable conditions. The economy of slave production was at the cost of the lives of Black women who were consistently raped to produce free slaves for their white colonial masters, some of which were physicians like <a href="https://www.dukeupress.edu/public-privates">James Marion Sims</a>. Sims, who also owned Black slaves at the time, operated on enslaved Black women who often developed a <a href="https://www.dukeupress.edu/public-privates">vesicovaginal fistula (VVF</a>), a condition where an opening is formed between the bladder and vagina causing urine to spill into the reproductive tract inducing symptoms of extreme pain and discomfort, impairing their ability to conceive successfully.</p><p>Black enslaved women were treated for these <a href="https://www.dukeupress.edu/public-privates">conditions without anesthesia or consent</a>. White physicians treated these conditions to ensure enslaved women continued to serve their slave masters. Sims profited from the pain of enslaved women he viewed as medical experiments to bolster his career and facilitated the <a href="https://www.dukeupress.edu/public-privates">creation of the modern speculum</a> used today in clinical practice.</p><p><strong>Effects on Black Women’s Pain Treatment in Reproductive Healthcare Settings</strong></p><p>Today, evident in the results of emerging research in the U.S. and Canada, <a href="https://open.library.ubc.ca/soa/cIRcle/collections/ubctheses/24/items/1.0447580">my research </a>included highlighting Black women and infants experiencing <a href="https://doi.org/10.1080/01459740.2018.1549389">higher incidences of complications and mortality rates</a>. Scholars identify how myths about the Black body and its <a href="https://doi.org/10.1016/j.socscimed.2022.115365">higher pain threshold are purely “socially constructed” </a>and used to delegitimize the disproportionately high rates of healthcare providers’ dismissal of Black patients’ pain during labour, delivery, and postpartum.</p><p>Also known as <a href="https://doi.org/10.1016/j.socscimed.2022.115365">“obstetric hardiness”</a> Black women are thought to be able to deliver children painlessly. This racist logic that Black women are intrinsically predisposed to make children and endure pain, originates from the colonial justification of sexual violence against Black women which permeates medical systems today. <a href="https://doi.org/10.1080/01459740.2018.1549389">Obstetric racism</a> is the major contributor and reason why medical care providers unconsciously dismiss Black women’s pain if they are trained to believe race-based taken-for-granted truths about the Black maternal body.</p><p><strong>How Can the Past Continue to Shape the Future?</strong></p><p>My master’s and undergraduate research findings were gathered from 25 qualitative one-on-one interviews. A <a href="https://open.library.ubc.ca/soa/cIRcle/collections/ubctheses/24/items/1.0447580">consistent finding </a>was that Black women feel unheard and dismissed by healthcare providers who perceive Black women to have higher pain tolerances. Despite the participant’s socioeconomic background, occupation, and knowledge of the healthcare system, <a href="https://open.library.ubc.ca/soa/cIRcle/collections/ubctheses/24/items/1.0447580">Black Canadian women continue to receive inadequate and inappropriate pain medications</a> to manage their birth and postpartum. Therefore, the past informs the future.</p><p>The torture and treatment of enslaved Black women continue to shape the assumptions providers make about Black women in North America, evidence being the high mortality rates and race-based data gathered in America. For instance, the <a href="https://www.cdc.gov/womens-health/features/maternal-mortality.html?CDC_AAref_Val=https://www.cdc.gov/healthequity/features/maternal-mortality/index.html">U.S. Centre for Disease Control and Prevention (CDC)</a> reported that Black women are three times more likely to die of pregnancy-related causes than white women. Maternal health research and continued awareness of the historical legacies of oppression that reinforce medical practices that harm Black women today are prevalent.</p><p>Awareness must be drawn on the micro and macro levels of patient and provider interactions that perpetuate dismissal of Black women’s pain in Canada. Equity begins when medical interventions, providers, and medical systems all work together to create safe spaces for Black women to seek care without judgment and adequate maternal health interventions.</p><p>Amplifying and developing awareness for the ways Black women have been historically and perpetually marginalized in maternal health spaces directly contributes to addressing systemic and<a href="https://open.library.ubc.ca/soa/cIRcle/collections/ubctheses/24/items/1.0447580"> implicit biases</a>. Further action is required with continued research on Black maternal health in Canada, acknowledgement of historical oppression, and future community-driven initiatives that centre Black women’s voices in medicine.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1a5609bcd621" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why We Should Work Together: Partnering With Patients to Close Gaps in Underdiagnosed Female Health…]]></title>
            <link>https://womenshealth-blog.medium.com/why-we-should-work-together-partnering-with-patients-to-close-gaps-in-underdiagnosed-female-health-ef86fb29b44a?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/ef86fb29b44a</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 26 Jun 2026 16:23:44 GMT</pubDate>
            <atom:updated>2026-06-26T16:23:44.738Z</atom:updated>
            <content:encoded><![CDATA[<h3><strong>Why We Should Work Together: Partnering With Patients to Close Gaps in Underdiagnosed Female Health Conditions.</strong></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*d8N7_RjMTiauQF1ASw-XKw.png" /></figure><p><strong>Author</strong>:<strong> </strong>Halle Deakin, MSc Student in Community Health Sciences; Cumming School of Medicine | <strong>Editors</strong>: Romina Garcia de leon, Tashi Stampp (blog coordinators) <strong>Reviewer</strong>: Emily Anne Opala MSc.</p><p><strong>Published</strong>: June 26th, 2026</p><p><em>Lived Experience as Expertise</em></p><p>As readers of women’s health blogs, we understand that many gaps still exist in how to best diagnose, and care for females living with <a href="https://pubmed.ncbi.nlm.nih.gov/41054717/">polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS</a>), <a href="https://pubmed.ncbi.nlm.nih.gov/30790565/">endometriosis</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/39906677/">premenstrual dysphoric disorder (PMDD)</a> and more. Female health is persistently underfunded and under-researched, with those living with these conditions facing greater challenges as diagnosis may take up to <a href="https://pubmed.ncbi.nlm.nih.gov/41054717/">15 years</a>. In many articles, this process has been described as an <a href="https://bloomwell.org.uk/articles/endometriosis-the-uphill-battle-to-being-believed">uphill battle</a>, where females commonly <a href="https://www.endocrine.org/news-and-advocacy/news-room/2018/women-with-polycystic-ovary-syndrome-dissatisfied-with-medical-care">face neglect from care providers</a>, <a href="https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1185769/full">dismissal of symptoms </a>and <a href="https://exploringhealth.org/2026/05/04/medical-dismissal-of-womens-pain/">harmful stigma</a> from those who should be helping them. Unfortunately, the challenges do not end here: after receiving a diagnosis, many find themselves with <a href="https://pubmed.ncbi.nlm.nih.gov/37198676/">limited guidance</a> on condition management.</p><p>Those living with these conditions are experts in the care journey, the shortcomings of the healthcare system, and existing knowledge gaps. They understand these experiences better than researchers ever can and they have a stake in the research being produced; they should have equal say in how it’s conducted.</p><p>Females with lived experience of these conditions are positioned to contribute their experience as expertise within research teams, ensuring research is responsive to their own and their greater community’s needs. With so much more to understand about these conditions, it is essential to prioritize the immediate needs of those affected, by representing and valuing their perspectives as equal to researchers.</p><p><em>An Outdated Approach</em></p><p>Females have been historically excluded from participating in research and it was not until <a href="https://orwh.od.nih.gov/toolkit/recruitment/history">1993</a> that they were even able to participate in clinical trials. Since then, the involvement of females with lived experiences in research has largely been limited to the role of ‘participant’, where they have little control over how the study is conducted. In this traditional approach, despite being the ones affected by research, they have had little say in the questions being asked, how data is analyzed or how these results are shared. Collecting data from females living with PMOS, endometriosis, PMDD, and other under-researched conditions is an important step in learning more about female health. However, supporting their perspectives as study designers, data analysts, and knowledge sharers is equally important for shaping meaningful research.</p><p><em>A New Beginning</em></p><p><a href="https://absporu.ca/patient-engagement/definitions/">Patient-oriented research</a>, research that engages those with lived experience, is becoming more recognized as a way of improving care outcomes. Yet, in a disturbingly familiar pattern, there are <a href="https://pubmed.ncbi.nlm.nih.gov/40165274/">limited examples</a> involving females living with these conditions as partners in research. It is time for this mindset to shift from treating females as passive research participants to active collaborators.</p><p>As <a href="https://absporu.ca/patient-engagement/definitions/">patient partners</a>, those living with these conditions are treated as equal members of the research team and contribute their valuable lived experience to inform all stages of the research. Clinicians and academics need to acknowledge the value that females with lived experience bring to research teams and that this expertise is as important as research credentials and skills. By becoming patient partners, these individuals can represent voices that typically go unheard and can drive meaningful change in research that aligns with patient priorities.</p><p>Patient advisory councils are an example of how patient partners can collaborate with researchers and clinicians to incorporate their insights throughout the research process. Through these, they can build community among females with similar lived experience and work together with the research team to drive change in the research that affects them.</p><p><em>Spearheading Change</em></p><p>Although few, there are research groups with established patient advisory councils that are setting an example of how to support the lived perspective in research for these conditions. Some examples include <a href="https://yonglab.med.ubc.ca/endometriosis-patient-research-advisory-board/">The Endometriosis and Pelvic Pain Laboratory</a> and <a href="https://embracelab.ca/our-work/">The EMBRACE Women’s Health Research Lab</a>, which are changing the traditional narrative through their initiatives. Many patient advocacy groups for these conditions are also doing impactful work to increase awareness of existing gaps. Still, there is a need for more groups that unite clinicians, researchers, and people with lived experience to tackle these problems<strong> </strong>together<strong>.</strong></p><p><em>Improving Care Together</em></p><p>Collaborating with females with lived experience of PMOS, endometriosis, PMDD, and other conditions as partners in research will ensure that research is more responsive to these communities. Their involvement will make sure that the limited funding for female health is spent answering meaningful questions that will improve the patient experience rather than merely bolster researchers’ CVs. Importantly, many patient partners also experience <a href="https://bmjopen.bmj.com/content/3/1/e001570">improved care outcomes</a> by working alongside others with lived experience, feeling empowered, gaining control and developing new skills.</p><p>Moving forward, females living with these conditions should be encouraged to join research teams and help shape research that fills the gaps they have experienced first hand.</p><p>If you are a female with lived experience, a friend or family member of one, a researcher, or a clinician, it’s time to advocate to engage those with lived experience in future female health research.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ef86fb29b44a" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Your Feed Isn’t Neutral: How Biases Influence Women’s Health Information Online]]></title>
            <link>https://womenshealth-blog.medium.com/your-feed-isnt-neutral-how-biases-influence-women-s-health-information-online-aeb75e11b742?source=rss-d18e0e1e374f------2</link>
            <guid isPermaLink="false">https://medium.com/p/aeb75e11b742</guid>
            <dc:creator><![CDATA[Women's Health Blog]]></dc:creator>
            <pubDate>Fri, 12 Jun 2026 16:01:01 GMT</pubDate>
            <atom:updated>2026-06-12T17:37:40.109Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*GKBGyeuzxorNOg2i5bnUsw.png" /></figure><p><strong>Author:</strong> Jade Helene Dufour, MSc &amp; MA, University of Ottawa | <strong>Editors:</strong> Tashi Stampp and Romina Garcia de leon (blog coordinators)</p><p><strong>Published: </strong>June 12th, 2026</p><p><strong>In today’s fast-moving digital world, do people turn to social media for health and mental health information? If so, what’s driving that shift?</strong></p><p>Research <a href="https://doi.org/10.2196/ijmr.7000">supports</a><a href="https://doi.org/10.3390/healthcare9121740"> that</a> searching for health and mental health information online has become most people’s first line of action when they have questions. Part of this shift is <a href="https://doi.org/10.2196/38340">motivated</a><a href="https://doi.org/10.3389/fpubh.2023.1315393"> by</a><a href="https://doi.org/10.2196/53233"> the</a> convenience, availability, affordability, and ease of access of the internet. The other reason for this shift is the challenge of accessing more formal information sources like psychoeducation via mental health professionals, or journal articles about symptoms or treatments. Some people may find diagnostic language complex to interpret or intimidating, which could deter them from looking further into official information sources. Others may lack the capability to use correct terminology to properly identify and express their needs. Regardless of its accuracy, the short, concise, and digestible educational content on social media has been able to fill this gap.</p><p><strong>What do social scientists understand about how people can be influenced to believe this information?</strong></p><p>Social media constantly exposes people to content about physical and mental health, often when they are not actively seeking it out. Over time, in these repeated <a href="https://www.researchgate.net/publication/239549964_Information_Encountering_A_Conceptual_Framework_for_Accidental_Information_Discovery"><em>accidental information encounters</em></a> users begin to build an understanding of a specific topic. As a user engages more with certain content, the algorithm will push similar videos to this user, creating a platform of specific information, known as an <em>“echo-chamber”</em>. The repeat exposure to this content will then strengthen a user’s belief in the information’s accuracy and may lead the user to then share this information with their social circle. This cycle is referred to as the <a href="https://doi.org/10.1111/sipr.12077">Misinformation Belief and Dissemination Model</a>.</p><p>Content creators often use <a href="https://betterlegalinfo.ca/wp-content/uploads/2019/12/Sundar-paper.pdf">credibility cues</a> in their videos like asserting their expertise through their titles (i.e., Doctor, Psychotherapist, ect), or their clothes (i.e., wearing a lab coat or scrubs). Also, the use of ‘you’ language invites the viewer to identify with the content. The more content has likes, views, and comments, which indicate an overall positive response from the wider audience, the more viewers are likely to approve the content as well. A recent example of this was featured in an earlier <em>Behind The Science </em>blog from WRHC, which addressed common misconceptions about <a href="https://womenshealthresearchcluster.com/learn/womens-health-blog/what-the-science-really-says-about-tylenol-use-during-pregnancy/">Tylenol use during pregnancy</a> that arose after President Trump’s comments on the topic went viral.</p><p><strong>When it comes to women’s health content, is there tension between making information accessible and reinforcing simplified or polarized narratives?</strong></p><p>My experience with health-related social media research tells me that there is definitely tension between making information accessible and reinforcing narratives when it comes to online content, especially short-form content like Instagram reels, YouTube shorts, or TikTok videos. It can be difficult to communicate complex health information in a 30-second video, while also keeping it understandable and engaging for the average person. For this reason, content creators may rely on longstanding narratives as a way to meet their audience halfway. It is also a way of ensuring that a larger audience benefits from accessing this information. This is part of the reason why much of the content online falls into heteronormative and cisgendered tropes and fails to address audiences that exist outside these binaries (e.g., <strong>members of the 2SLGBTQI+ community</strong> like homosexual people, non-binary folks, transgender people, ect.). This may also help explain why so many creators rely on credibility cues, like those I described in the previous section.</p><p><strong>If our feeds aren’t neutral, what should we be <em>“scrolling out for”</em>, and how can we avoid being misled by online content discussing women’s health and mental health information?</strong></p><p>When scrolling social media, it’s important to keep in mind that technology is not neutral and neither is your algorithm. <a href="https://doi.org/10.5817/MUJLT2024-1-4">Technology is designed</a> around a certain set of values and a specific perspective of the world. These values impact both the creators and users of social media platforms. As mentioned above, the short-form nature of content on your feed relies on certain assumptions to achieve its informative goals. These same assumptions are often integral to the design and training of algorithms. <strong>For an algorithm to recommend “women’s health” content, it first has to decide what counts as “woman” and what counts as “health”.</strong> The definitions algorithms use are determined by the people responsible for the technology. Today, <a href="https://sproutsocial.com/insights/twitter-algorithm/">many</a><a href="https://www.udit.es/en/tiktok-inteligencia-artificial-y-probabilidad-matematica/"> social</a><a href="https://sproutsocial.com/insights/instagram-algorithm/"> media</a><a href="https://sproutsocial.com/insights/youtube-algorithm/"> algorithms</a> are AI-driven, which can further reinforce predetermined ideas of “woman” and “health”. It is crucial to think about both the motivations behind the design and the messages you are engaging with.</p><p><strong>How does your research help us understand the ways people encounter health information online, and have you seen specific social media platforms play a unique role in shaping that experience?</strong></p><p>I’ve had the opportunity to work on research involving both X (formerly Twitter) and TikTok. Through working with these platforms, it is clear that there are audiences actively engaging with health and mental health information on social media. My research on X found that health and mental health information is often shared in a mostly unconscious effort to build community, either between individual users or between users and organizations providing resources. The results of my TikTok project suggested that the platform is more geared towards information sharing from a professional or individual to an audience, representing a more unidirectional relationship than what is typically seen on X.</p><p>Outside of my work, <a href="https://doi.org/10.2196/ijmr.7000">studies</a><a href="https://doi.org/10.3390/healthcare9121740"> support</a> that younger women in caregiver roles, who are employed, have completed higher education, have higher incomes, and own smartphones are among those most likely to encounter online health and mental health content. As social media continues to shape how people learn about health, I hope to explore more closely how these experiences differ across gender identities and communities.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=aeb75e11b742" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>